Purchase Order 33315219P00414546
- Not listed
- The Smithsonian Institution awarded a $7,790 firm fixed-price purchase order to Admera Health LLC for sequencing services. The contract, issued on February 15, 2023, with an ultimate completion date of June 30, 2023, was not structured as a set-aside. Admera Health LLC, a minority-owned, self-certified small disadvantaged business headquartered in South Plainfield, New Jersey, specializes in advanced genomic services including DNA and RNA sequencing, library preparation, and bioinformatics...
- This contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Admera Health LLC, a minority-owned, small disadvantaged business, for next-generation sequencing services. The $47,250.00 firm-fixed-price purchase order has a completion date of September 30, 2020 and was not set aside. Admera Health LLC is a subsidiary of Azenta, Inc., a leading provider of life sciences solutions including sample management and genomic services...
- This is a $23,995.00 firm-fixed price Purchase Order contract awarded by the U.S. Department of Agriculture (USDA) Forest Service to Admera Health LLC, a minority-owned small disadvantaged business, to provide library construction and Illumina whole genome sequencing services for at least 40 GB per sample for 100 DNA extracts. The contract is a Total Small Business set-aside and has an ultimate completion date of September 30, 2024. This contract was awarded under a competitive solicitation (RFQ...
- The Department of the Interior's U.S. Geological Survey Office of Acquisitions and Grants awarded a $12,600 firm fixed price purchase order to Admera Health LLC, a minority-owned, self-certified small disadvantaged business, for pair end sequencing services. The purchase order, set aside for total small business, is to be completed by April 2, 2021 with a period of performance in Lakewood, Colorado. Admera Health LLC is a subsidiary of Azenta, Inc., which does business as Brooks and provides...
- Admera Health LLC, a minority-owned small disadvantaged business and subsidiary of Genewiz LLC, was awarded a $14,640 firm fixed-price purchase order by the U.S. Department of Agriculture's Northeast Area on September 4, 2019, for whole genome sequencing of pooled samples of rainbow trout. The contract, designated as a small business set-aside, was completed by January 31, 2020, with work performed at Admera Health's facility in South Plainfield, New Jersey. This engagement supports the USDA's...
- Admera Health LLC was awarded a $6,300 firm fixed price purchase order by the Department of the Interior's United States Geological Survey Office of Acquisitions and Grants to provide biopharma services in support of the original solicitation for mineral separation services. As a minority-owned, self-certified small disadvantaged business, this contract was set aside for total small business. Admera Health will leverage its expertise in next generation sequencing, RNA extraction, sequencing of...
- The U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) awarded a $52,000.00 firm-fixed-price purchase order contract to Admera Health LLC, a minority-owned small disadvantaged business, to extend the application of single-cell sequencing technology with the latest generation of genomics technologies. The contract has a period of performance through September 24, 2025. The award is not set aside, but Admera Health has a history of being awarded USDA contracts set aside...
- The U.S. Department of Agriculture Agricultural Research Service awarded a small-business set-aside purchase order to Admera Health LLC for $29,988 on September 30, 2025, covering RNA sequencing services for 252 samples with 80M paired-end 150x2 reads generating 12 GB of data per sample. Admera Health is a minority-owned, self-certified small disadvantaged business. Work is performed at North River, North Dakota, and includes RNA quality control, mRNA-sequencing library construction, and...
- This is a $7,632.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) to Admera Health LLC, a minority-owned and self-certified small disadvantaged business, for RNA sequencing services. The contract is set aside for total small business participation. The contract supports the USDA-ARS Vegetable Crops Research Unit's need for RNA sequencing (transcriptome sequencing) of 48 cucumber samples to study the molecular...
- The U.S. Department of Agriculture (USDA) Agricultural Research Service awarded a $12,480.00 firm-fixed-price purchase order contract to Admera Health LLC, a minority-owned, self-certified small disadvantaged business, for RNA sequencing services to support research on pecan shuck decline disease. The contract is a total small business set-aside under NAICS code 541380 (Testing Laboratories and Services) with a small business size standard of $19 million. The contract requires comprehensive...
This is a $43,142.50 firm fixed price purchase order contract awarded to Admera Health LLC, a minority-owned, small disadvantaged business, by the Smithsonian Institution, a civilian federal agency. The contract is for genetic sequencing services, including next-generation sequencing, RNA extraction, and whole genome sequencing. Over time, Admera Health has expanded its services and customer base, providing these services to multiple government agencies such as the Department of Veterans Affairs, Department of Agriculture, Department of the Interior, and Department of Health and Human Services. The contract does not have a set-aside designation. Admera Health is a subsidiary of Azenta, Inc., a leading provider of life sciences solutions to federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and National Aeronautics and Space Administration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | $831 | 12/7/22 | |
| P00001 | Funding Only Action | $0 | 12/13/18 | |
| Not listed | Not listed | $42.3k | 12/13/18 |